<DOC>
	<DOCNO>NCT00958152</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetics , safety , tolerability co-administration VCH-222 telaprevir healthy subject .</brief_summary>
	<brief_title>Drug-Drug Interaction Study VCH-222 Telaprevir Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Healthy male , and/or healthy female nonchildbearing potential , age 18 55 year ( inclusive ) Body mass index ( BMI ) 18 31 kg/m2 ( inclusive ) weight &gt; 50 kg Women child bear potential Subjects positive Hepatitis B , Hepatitis C , HIV Subjects participate clinical study involve administration investigational drug within 2 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>VX-950</keyword>
	<keyword>VX-222</keyword>
	<keyword>STAT-C</keyword>
</DOC>